Thrombocytopenic disorders in critically ill patients

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 I, 2000, Pages 347-351

  Drews, Reed E ^a,b   Weinberger, Steven E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; GOLD; HEPARIN; LACTATE DEHYDROGENASE; QUINIDINE; QUININE; VALPROIC ACID;

CRITICAL ILLNESS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED DISEASE; HEMOLYTIC UREMIC SYNDROME; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0033845363     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.2.ncc3-00     Document Type: Review

References (32)

1. The incidence and cause of coagulopathies in an intensive care population
2. Thrombocytopenia in a surgical ICU
3. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid
4. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production
5. Drug-induced thrombocytopenia: A systematic review of published reports
6. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
7. Disseminated intravascular coagulation
8. Protein C in the treatment of coagulopathy in meningococcal disease
9. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome
10. Cancer procoagulant: A factor X activator, tumor marker and growth factor from malignant tissue
11. Annexin II and bleeding in acute promyelocytic leukemia
12. Antithrombin III in patients with severe sepsis: A randomized, placebo-controlled, double-blind multicenter trial plus meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
13. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia
14. The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification
15. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women
16. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: The benefits of corticosteroids
17. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome
18. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count)
19. Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome: Four cases and a review
20. Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenia purpura
21. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Diagnosis and management
22. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults
23. Moschcowitz, multimers, and metalloprotease
24. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura
25. Splenectomy done during hematologic remission in patient with thrombotic thrombocytopenic purpura
26. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura
27. Heparin-induced thrombocytopenia: Towards consensus
28. Heparin-induced thrombocytopenia: A ten-year retrospective
29. First workshop for detection of heparin-induced antibodies: Validation of the heparin-induced platelet-activation test (HIPA) in comparison with PF4/heparin ELISA
30. The perils of platelet transfusions
31. Final statement from the consensus conference on platelet transfusion
32. Clinical consequences of alterations in platelet transfusion dose: A prospective, randomized, double-blind trial